Company news

Ribomic, Inc. news in 2023

Ribomic, Inc.'s news releases, calls and decks from 2023, newest first.

View company

RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)

December 5, 2023